Error-augmented Walking on Gait Performance and Brain Activities in Stroke

NCT ID: NCT04455334

Last Updated: 2022-06-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-13

Study Completion Date

2023-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This three-year study is proposed to document the effect and further implementation of error-augmented walking on gait performance and brain activities in individuals with stroke. Note that brain activations of post-stroke individuals during locomotion is a relatively unexplored realm. In the first year, study aims to observe the gait performance and brain activity of post-stroke and healthy participants when they walk on the split-belt treadmill, which inputs errors and causing adaptation during locomotion. Second year, study focuses on the long-term effect in aspect of brain activation and gait performance after training the post-stroke individuals with error-augmented treadmill walking. Lastly, study aim to investigate the long-term effect of practically applying the concept of error-augmented training strategy into clinical physical therapy.

The first-year study is a cross-sectional study to recruit post-stroke and healthy participants. Gait performance will be measured by GaitUp system and brain activity during each walking trails will be measured concurrently by functional near infrared spectroscopy (fNIRS). Cadence, stride time, stride length and swing cycle are the gait parameters that will be recorded. Also, symmetry ratio and variability of temporal and spatial parameters will also be calculated. Brain area of interest in this study will be bilateral premotor cortex (PMC), supplementary motor area (SMA) and medial part of primary motor cortex (M1). Study will run one-way analysis of variance (ANOVA) with repeated measures and, if needed, Tukey post hoc test will be used to document the within group and between group differences with p\<.05.

The second year and third year study are single-blinded (assessor), randomized controlled trials. In the second year, study will recruit and randomize post-stroke participants into one of the two training groups, error-augmented treadmill training group (ETT group) and active control group (AC group). In ETT group, participants will practice split-belt treadmill walking. And participants in AC group will received traditional treadmill walking. The training duration will be 40 minutes per session, 3 sessions per week for a total of 4 weeks for every group. There will be three evaluations, chronologically, on one day before intervention, one day after completion of intervention and one month after completion of intervention. Gait performance, brain activity, dynamic gait index and sensorimotor ability of lower extremity will be documented. Two-way ANOVA and Tukey post-hoc test will be used to determine the training and follow-up effects with p\< .05. During the third year, individuals with stroke will be recruited and randomized to one of the two group, error-augmented concept combined physical therapy group (EAPT group) and conventional physical therapy group (CPT group). Participants in the CPT group will receive thirty-minute conventional physical therapy each session. Instead of training on a split-belt treadmill, participants in EAPT group will receive fifteen-minute walking trainings that implement the error-augmented concept and another fifteen-minute conventional physical therapy each session. The training duration will be 40 minutes per session, 3 sessions per week for a total of 4 weeks for every group. The outcome measurements, and statistical analysis are the same as those described in the second year.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

healthy

year 1 study

Group Type OTHER

NO INTERVENTION

Intervention Type OTHER

NO INTERVENTION

stroke

year 1 study

Group Type OTHER

NO INTERVENTION

Intervention Type OTHER

NO INTERVENTION

active control group

year 2 study

Group Type ACTIVE_COMPARATOR

active control group

Intervention Type OTHER

walk on tie-belt treadmill

Error-augmented treadmill training

year 2 study

Group Type EXPERIMENTAL

Error-augmented treadmill training

Intervention Type OTHER

walk on split-belt treadmill

Error-augmented concept combined physical therapy group

year 3 study

Group Type EXPERIMENTAL

Error-augmented concept combined physical therapy group

Intervention Type OTHER

Error-augmented concept combined physical therapy

conventional physical therapy group

year 3 study

Group Type ACTIVE_COMPARATOR

conventional physical therapy group

Intervention Type OTHER

conventional physical therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Error-augmented treadmill training

walk on split-belt treadmill

Intervention Type OTHER

active control group

walk on tie-belt treadmill

Intervention Type OTHER

Error-augmented concept combined physical therapy group

Error-augmented concept combined physical therapy

Intervention Type OTHER

conventional physical therapy group

conventional physical therapy

Intervention Type OTHER

NO INTERVENTION

NO INTERVENTION

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. first unilateral stroke
2. older than 20 years old
3. medically stable
4. lesion site limited in subcortical area
5. having step length asymmetry (asymmetry ratio ≥ 1.08)
6. ability to walk 10 meters independently without an assistive device.


1. ability to walk 10 meters independently without an assistive device
2. no any other neurological, psychological, or orthopedic disorders known to interfere the walking performance
3. mini-mental status examination scores \> 24 points

Exclusion Criteria

1. Participants who are medical unstable
2. cognitive impaired (mini-mental status examination scores \< 24 points)
3. diagnosed with other neurological, psychological, or orthopedic disorders known to interfere the participation to the study
4. with the diagnosis which the contraindication includes exercise
Minimum Eligible Age

20 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yanci Liu, Ph.D

Role: PRINCIPAL_INVESTIGATOR

National Taiwan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan University Hospital

Taipei, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yanci Liu, Ph.D

Role: CONTACT

0233668135

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yanci Liu, PHD

Role: primary

0233668135

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202004042RIND

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.